Gastroenterology

The field of gastroenterology is as wide as the the amount of the body that it covers. Because of this there are certain challenges doctors face whether they treat the entire gastrointestinal system or just specific parts.

For certain late stage abdominal cancer patients a specialized procedure called hyperthermic intraperitoneal chemotherapy can provide a "new lease on life," as a specialized treatment method.

Researchers evaluated the effects of ursodeoxycholic acid supplementation on nutritional status in patients with mild liver disease.

Although generally the most effective intervention for morbid obesity, bariatric surgery does not result in predictable weight loss patterns.

Despite green tea’s many health benefits, combining it with dietary iron does not produce any benefits for inflammatory bowel disease (IBD) patients.

The treatment of pancreatitis has taken great strides in recent years including the ability to help patients through non-surgical options.

Exercise during early life may alter the gut microbe, in addition to promoting healthy brain and metabolism, according to findings published in the journal Immunology and Cell Biology.

For patients with achalasia simple tasks like eating and drinking can be nearly impossible causing health problems including severe weight loss. A new minimally invasive procedure aims to to help get these patients back to a normal quality of life within a day after surgery.

Migraine and tension headaches potentially share genetic links with irritable bowel syndrome (IBS).

Why should primary care physicians consider the concierge model of medicine? The question should really be rephrased: Why shouldn't they?

A new analysis of cohort study data estimates the average annual cost of caring for children with chronic pancreatitis or acute recurrent pancreatitis in the US now approaches $50,000.

The European Commission has approved expanded use of a Bristol-Myers Squibb hepatitis C drug to include patient populations with decompensated cirrhosis, HIV-1 coinfection and post-liver transplant recurrence of the virus.

Potential new treatment options could develop from research conducted at North Carolina State University and University of Michigan involving secondary bile acids.

The US Food and Drug Administration (FDA) has approved dexlansoprazole (Dexilant SoluTab/Takeda Pharmaceuticals), a new formulation for the treatment of heartburn-associated gastroesophageal reflux disease (GERD) in adults age 18 and older.

Often, patients suffering from gastrointestinal issues are too embarrassed or uncomfortable to schedule a colonoscopy.

A multi-study analysis shows that a majority of patients with hepatitis C maintained sustained virological response five years after they were treated but researchers found higher risk of reinfection among patients in two subgroups.

A new randomized controlled trial hints that pancrelipase may do better than conventional pancreatic enzyme supplementation in protecting against non-alcoholic fatty liver disease in pancreatic cancer patients who undergo pancreatoduodenectomy.

Cheese contains a natural food preservative, nisin, which can destroy cancer cells.

Patients suffering from irritable bowel syndrome (IBS) can reduce their symptoms with the substance ebastine found in histamines used to treat hay fever.

It was not long ago that patients with hepatitis C were among the leading candidates for liver transplants. Now that many forms of the disease are curable that attention can be turned to other patients in need.

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

The US Food and Drug Administration recently approved the Fenix Continence Restoration System for the treatment of fecal incontinence for patients who have tried and failed other medical and surgical options.

Four types of gut microbiota acquired in infancy may protect babies from developing asthma, according to findings published in Science Translational Medicine.

New research from Japan indicates that exocrine pancreatic insufficiency after pancreatectomy may be 1 of several factors that indicates an elevated risk of postoperative hepatic steatosis.

Francisco Sylvester, MD, UNC School of medicine emphasized the importance of applying study findings to early interventions in treatment.